FDA Inspection 704675 — Biotest Medical Corp

Biotest Medical Corp — FEI 3004644399

The FDA completed an inspection of Biotest Medical Corp on November 18, 2010 in Taichung City. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 7 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
November 18, 2010
Fiscal Year
2011
Product Type
Devices
Project Area
Compliance: Devices
Location
Taichung City (Taiwan)

Citations

IDCFRDescription
1471321 CFR 820.198(a)Lack of or inadequate complaint procedures
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
320621 CFR 820.50(b)Approval, inadequate purchasing data
326421 CFR 820.250(b)Sampling methods - Lack of or inadequate procedures
368321 CFR 820.70(g)Equipment Installation, Placement, Specified Requirements
63221 CFR 803.17(a)(2)Lack of System for Determining MDR Events